Personal information

Activities

Collapse all

Employment (1)

KU Leuven: Leuven, BE

2019-10-14 to present | PhD Student (Oncology)
Employment
Source: Self-asserted source
Tommaso Scolaro

Education and qualifications (2)

University of Padua: Padova, Veneto, IT

2016-10-01 to 2018-12-04 | Master degree in Molecular Biology (Biology)
Education
Source: Self-asserted source
Tommaso Scolaro

University of Padua: Padova, Veneto, IT

2013-10-01 to 2016-09-26 | Bachelor Degree in Molecular Biology (Biology)
Qualification
Source: Self-asserted source
Tommaso Scolaro

Professional activities (1)

Instituto de Medicina Molecular: Lisboa, PT

2019-02-01 to 2019-06-30 | Erasmus Student
Invited position
Source: Self-asserted source
Tommaso Scolaro

Funding (1)

Tampering with the pyrimidinergic signalling in macrophages to overcome immunotherapy resistance

2021 to 2025 | Contract
Fonds Wetenschappelijk Onderzoek (Leuven, BE)
Source: Self-asserted source
Tommaso Scolaro

Works (3)

Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance

Nature Cancer
2024-06-06 | Journal article
DOI: 10.1038/s43018-024-00771-8
Contributors: Tommaso Scolaro; Marta Manco; Mathieu Pecqueux; Ricardo Amorim; Rosa Trotta; Heleen H. Van Acker; Matthias Van Haele; Niranjan Shirgaonkar; Stefan Naulaerts; Jan Daniluk et al.
Source: check_circle
Crossref

How metabolism bridles cytotoxic CD8<sup>+</sup> T cells through epigenetic modifications.

Trends in immunology
2021-04-15 | Journal article
DOI: 10.1016/j.it.2021.03.006
PMID: 33867272
Source: Self-asserted source
Tommaso Scolaro

The Metabolic Signature of Macrophage Responses.

Frontiers in Immunology
2019-07-03 | Journal article
DOI: 10.3389/fimmu.2019.01462
PMID: 31333642
PMC: PMC6618143
Source: Self-asserted source
Tommaso Scolaro
How many people are using ORCID?